Civitas Resources Closes $750M Debt Deal: What’s the Catch? 🤔 Welcome back to the Civitas Resources saga, folks! Consider this your definitive guide to the...
CISO Global Dodges Delisting Bullet: Back from the Brink (and Profitable?) Welcome back to the ongoing saga of CISO Global, the cybersecurity firm that keeps...
Cognition Therapeutics Gets a Philanthropic Boost: Zervimesine Expanded Access Program for DLB Launched! Welcome back to the ongoing saga of Cognition Therapeutics (CGTX), where we...
Bluejay Diagnostics: Downsizing, Cash Crunch, and a $30 Million Question Mark – The June 2025 Update Welcome back to the ongoing saga of Bluejay Diagnostics...
BioCryst Extends CFO’s Consulting Gig: Smooth Transition or Golden Parachute 2.0? Welcome back to the ongoing saga of BioCryst Pharmaceuticals, Inc. (BCRX), where we dissect...
Booz Allen Gets a New Brain: Ex-National Security Advisor Joins the Board Welcome back to your regularly scheduled Booz Allen Hamilton Holding Corporation (BAH) deep...
ASPI Pivots to Cancer-Fighting Isotopes (and South African Safaris?): Decoding the June 4th 8-K Welcome back to the ongoing saga of ASP Isotopes Inc. (ASPI),...
Arista Networks: Shareholders Give a Resounding “Meh” (But in a Good Way) Welcome back to the ongoing saga of Arista Networks, your one-stop shop for...
